The expressions and clinical significance of IGFBP-2,-3 in both serum and tumor tissues in patients with epithelial ovarian cancer

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 4, 2009, Pages 639-643

  Yan, Xiao Juan ^a   Tian, Ying ^a   Wang, Cui ^a   Wang, Xiao Ling ^a   Di, Jian Ming ^a   Cheng, Jian Xin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial ovarian cancer; Immunochemistry; Insulin like growth factor ii(IGF ii); Insulin like growth factor binding protein 2(IGFBP 2); Insulin like growth factor binding protein 3(IGFBP 3)

Indexed keywords

EID: 68149163434     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Baron-Hay S. Boyle F, Ferrier A, et al. Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res,2004, 10(5): 1796-1806.
2. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol,2000;183(1) :1-9.
3. Qiu Q, Basak A, Mbikay M, et al. Role of pro-IGF-H processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci U S A,2005;l02(31) :11047- 11052.
4. Kanety H, Kattan M, Goldberg I, et al. Increased insulin-like growth factor binding protein-2(IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid. Br J Cancer, 1996,73(9),1069-1073.
5. Hong J, Zhang G, Dong F, et al. Insulin-like growth factor(IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem,2002;277(12):10489-10497.
6. Torng PL, Lee YC, Huang CY, et al. Insulin-like growth factor binding protein-3(IGFBP-3) acts as an invasion- metastasis suppressor in ovarian endometrioid carcinoma. Oncogene,2008;27(15):2137-2147.
7. Giudice LC, Farrell EM, Pham H, et al. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab, 1990; 71(5) : 806- 816.
8. Bernard L, Babajko S, Binoux M, et al. The amino-terminal region of insulin-like growth factor binding protein-3,(1-95) IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells. Biochem Biophys Res Commun,2002;293(l),55-60.
9. Lalou C, Lassarre C, Binoux M. Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3. Horm Res, 1996;45(3-5) : 156-159.
10. Blat C, Villaudy J, Binoux M. In vivo proteolysis of serum insulin-like growth factor(IGF) binding protein-3 results in increased availability of IGF to target cells. 1 Clin Invest, 1994; 93(5):2286-2290.
11. Lee EI, Mircean C, Shmulevich I, et al. Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer,2005|4(1):7.
12. Jenkins PJ, Khalaf S, Ogunkolade W, et al. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis. Endocr Relat Cancer, 2005,12(4), 891-901.